Research Articles
Permanent URI for this communityhttp://197.255.125.131:4000/handle/123456789/22010
A research article reports the results of original research, assesses its contribution to the body of knowledge in a given area, and is published in a peer-reviewed scholarly journal. The faculty publications through published and on-going articles/researches are captured in this community
Browse
6 results
Search Results
Item High dose cyclophosphamide in drug resistant and relapsing Burkitt's lymphoma.(Ghana Medical Journal, 1979) Nkrumah, F.K.; Biggar, R.J.Item Presenting clinical features of Burkitt's lymphoma in Ghana, West Africa.(Journal of Tropical Pediatrics and Environmental Child Health, 1979) Biggar, R.J.; Nkrumah, F.K.; Perkins, I.V.Item Combination chemotherapy in abdominal Burkitt's lymphoma.(Cancer, 1977) Nkrumah, F.K.; Perkins, I.V.; Biggar, R.J.In a clinical trial, 42 patients with abdominal Burkitt's lymphoma (BL) were treated with a combination regimen, code-named CVA, consisting of cyclophosphamide (CTX), vincristine, and cystosine arabinoside. In addition, intrathecal methotrexate (i.t. MTX) was administered as prophylaxis against subsequent central nervous system (CNS) involvement. Induced remissions, relapse, and survival were compared with those in a preceding group of 44 patients with abdominal BL treated with CTX along. Remission rate did not differ significantly in the two treatment groups, although induced remissions were higher in the CVA plus i.t. MTX-treated group (94% vs. 83%). Remission duration was significantly increases (p less than .05) and CNS relapse significantly reduced (p less than .05) in the group treated with CVA and i.t. MTX. The combination therapy was associated with higher early deaths during treatment, which adversely affected the overally survival. It is suggested that a reduction of the initial chemotherapeutic doses, particularly for patients with extensive tumor load, could further improve on the results of this trial.Item Epstein-barr virus RNA in burkitt tumor tissue.(Cell, 1979) Dambaugh, T.; Nkrumah, F.K.; Biggar, R.J.; Kieff, E.Analysis of the viral RNA in four Burkitt tumor biopsies indicates that tumor tissue contains RNA homologous to at least 3–6% of the DNA of Epstein-Barr virus (EBV). Most of these RNA species accumulate in the polyadenylated RNA fraction of Burkitt tumor tissue. Two approaches have been used to determine the location within the EBV genome of the DNA sequences which encode stable RNA in two Burkitt tumor biopsies, F and S, which contain 6–10 copies per cell of at least 80% of the EBV genome. With the first approach, 32P-EBV DNA homologous to polyadenylated or nonpolyadenylated RNAs from the F, S or R tumors was hybridized to blots of fragments of EBV DNA. With the second approach, polyadenylated or nonpolyadenylated RNAs from the F or S tumors were hybridized to separated, labeled fragments of EBV DNA in solution. The results indicate that first, most of the viral RNA in Burkitt tumor tissue is encoded by approximately 20% of the Hsu I D fragment, 20% of the Eco RI A/Hsu I A double-cut fragment and 3% of the Hsu I B fragment of EBV DNA; second, an abundant RNA species in tumor tissue is homologous to the “additional DNA” present in the W91 and Jijoye/HR-I Burkitt tumor isolates of EBV and absent in the B95-8 virus, an isolate of EBV from outside the Burkitt endemic region; and third, there is little or no homology to other regions of the EBV genome.Item Tumour site and renal dysfunction as factors influencing leucopenia after chemotherapy for Burkitt's lymphoma.(British Journal of Cancer, 1979) Biggar, R.J.; Nkrumah, F.K.Forty-four (44) patients with Burkitt's lymphoma received identical combination chemotherapy on the basis of body surface area. Patients with renal dysfunction, more common in those with abdominal tumours, were at significantly greater risk of developing severe leucopenia (less than 1000 cells/dl) than those with normal renal function (P less than 0.0001). Similar results were seen in a series of 8 patients with normal marrows treated with only i.v. cyclophosphamide and intrathecal methotrexate. Giving a lower initial dose of cyclophosphamide seemed to reduce the risk of severe leucopenia in 5 additional patients with evidence of renal dysfunction. The mechanism is postulated as delayed excretion of the active metabolites of cyclophosphamide. Adjustment of the chemotherapeutic dose should be considered when treating patients with renal dysfunction.Item Burkitt's lymphoma in Ghana: Urban-rural distribution, time-space clustering and seasonality.(International Journal of Cancer, 1979) Biggar, R.J.; Nkrumah, F.K.Epidemiological data are summarized from 236 cases of Burkitt's lymphoma (greater than 90% cytologically or histologically confirmed) seen from 1970 through 1975 at Korle Bu Hospital, Accra, Ghana. The rate of referral from rural areas was greater than that from urban areas, despite a probable bias toward referral from urban areas. The distribution of cases in Ghana appeared to be non-random but we attribute this to variable access to medical care and physician interest. Rainfall did not appear to be an important factor. Seasonal variation and time-space clustering were not observed. The incidence here seems lower than that reported in East Africa. We found no evidence of an environmental influence with a short incubation period, as has been postulated for this disease in East Africa. The higher risk among rural patients is consistent with severe malaria being a factor in the etiology of Burkitt's lymphoma.